Literature DB >> 20447687

A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.

Michele Cea, Gabriella Cirmena, Anna Garuti, Ilaria Rocco, Claudia Palermo, Antonia Cagnetta, Eva Moran, Nicoletta Colombo, Raffaella Grasso, Giuseppina Fugazza, Marco Gobbi, Alessio Nencioni, Alberto Ballestrero, Franco Patrone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20447687     DOI： 10.1016/j.leukres.2010.03.036

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  5 in total

1.  Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring.

Authors:  Stephen E Langabeer; Sarah L McCarron; Johanna Kelly; Janusz Krawczyk; Suzanne McPherson; Kanthi Perera; Philip T Murphy
Journal:  Case Rep Hematol       Date:  2012-07-02

2.  Early Complete Molecular Response to First-Line Nilotinib in Two Patients with Chronic Myeloid Leukemia Carrying the p230 Transcript.

Authors:  Marianna Greco; Giovanni Caocci; Giorgio La Nasa
Journal:  Case Rep Hematol       Date:  2013-07-11

3.  Hyperdiploidy associated with T315I mutation in BCR-ABL kinase domain in an accelerated phase-chronic myeloid leukemia case.

Authors:  Walid Al-Achkar; Faten Moassass; Adnan Ikhtiar; Thomas Liehr; Moneeb Abdullah Kassem Othman; Abdulsamad Wafa
Journal:  Mol Cytogenet       Date:  2014-11-29       Impact factor: 2.009

4.  Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation.

Authors:  Jesus Paez-Mayorga; Andrew L Chen; Sivareddy Kotla; Yunting Tao; Rei J Abe; Emma D He; Brian P Danysh; Marie-Claude C Hofmann; Nhat-Tu Le
Journal:  Front Cardiovasc Med       Date:  2018-09-06

5.  Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia.

Authors:  Sarah L McCarron; Karena Maher; Johanna Kelly; Mary F Ryan; Stephen E Langabeer
Journal:  Case Rep Hematol       Date:  2013-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.